Skip to main
  1. Stocks
  2. Nektar Therapeutics
NKTR

Nektar Therapeutics (NKTR)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Nektar Therapeutics (NKTR) Stock

See the latest NKTR stock price, buy/sell Nektar Therapeutics shares with AI-powered fundamental data and custom analysis.

Start investing in Nektar Therapeutics (NKTR)

About Nektar Therapeutics (NKTR)

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headqua...read more
Market cap$1.3B
Yesterday's volume568.32K
Revenue (TTM)$54.59M
Avg. daily volume1.11M
EBITDA (TTM)-$129.95M
Open$37.52
Price / earnings ratio-5.67x
Yesterday's range$37.05 - $38.4
Debt / equity0.15x
52 week range$33.4 - $109
5 year debt / equity1.39x
Beta (LTM)1.05x
Interest coverage-5.14x
Dividend & yield$0.00 (0.00%)
Current ratio10.42x
Ex-dividend date
Next earnings
Dividend payable date

Nektar Therapeutics Stock Rating

What analysts recommend for NKTR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 55%
Buy 18%
Hold 27%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Oct 27, 2026, the market cap for NKTR stock is $1.3B

The current P/E ratio for NKTR stock is -5.67

The 52-week high for NKTR stock is $109. The current NKTR stock price $undefined is 100.00% below its 52-week high

The 52-week low for NKTR stock is $33.40. The current NKTR stock price $undefined has increased 100.00% from its 52-week low

No, the NKTR stock does not pay dividends to its shareholders

The target price for NKTR stock is $129.82 based on the average of what a group of analyst think NKTR stock could be worth at a future date. This is not a prediction by Public.com

How to buy NKTR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NKTR stock

    Navigate to the Explore page. Then, type NKTR into the search bar. When you see NKTR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NKTR stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Nektar Therapeutics Stock Earnings

The value each NKTR share was expected to gain vs. the value that each NKTR share actually gained.

Nektar Therapeutics (NKTR) reported Q2 2026 earnings per share (EPS) of -$1.23, beating estimates of -$2.04 by 39.71%. In the same quarter last year, Nektar Therapeutics's earnings per share (EPS) was -$2.95. Nektar Therapeutics is expected to release next earnings on , with an earnings per share (EPS) estimate of -$2.09.

Buy Nektar Therapeutics (NKTR) Stock

See the latest NKTR stock price, buy/sell Nektar Therapeutics shares with AI-powered fundamental data and custom analysis.

Start investing in Nektar Therapeutics (NKTR)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NKTR stock data and trends